Back to Search
JUDITH GREM, M.D.
M.D.
Family Medicine Physician
NPI: 1780610535Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD020070E(PA)
Research & Publications (20)
Intratumoral molecular or genetic markers as predictors of clinical outcome with chemotherapy in colorectal cancer.
PMID 15726514·Semin Oncol·2005
6-review
Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
PMID 11309351·Clin Cancer Res·2001
7-preclinical
Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancer.
PMID 11219972·Oncology (Williston Park)·2001
6-review
5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development.
PMID 11081567·Invest New Drugs·2000
6-review
National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.
PMID 19124811·Ann Intern Med·2009
8-other
National Institutes of Health consensus development conference statement: management of hepatitis B.
PMID 19399804·Hepatology·2009
8-other
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
PMID 18235116·J Clin Oncol·2008
3-trial
Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine.
PMID 19105824·BMC Cancer·2008
3-trial
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
PMID 18235115·J Clin Oncol·2008
3-trial
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function.
PMID 17699862·Clin Cancer Res·2007
8-other
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.
PMID 16168057·BMC Cancer·2005
3-trial
Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels.
PMID 16231011·Br J Pharmacol·2005
7-preclinical
Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors.
PMID 15774780·J Clin Oncol·2005
3-trial
A phase II and pharmacologic study of fluorouracil given by a 1-hour infusion daily for 5 days with leucovorin and interferon alpha-2a in adenocarcinoma of the large bowel.
PMID 15870935·Oncol Rep·2005
3-trial
A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors.
PMID 15930350·Clin Cancer Res·2005
3-trial
Severe disabling sensory-motor polyneuropathy during oxaliplatin-based chemotherapy.
PMID 15269607·Anticancer Drugs·2004
5-case
Adjuvant therapy for colon cancer: a historical perspective.
PMID 15292377·J Natl Cancer Inst·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- ROUTE 422, SPORTSMAN ROAD, BUILDING 37
WERNERSVILLE, PA 19565 - Phone
- (610) 678-3411
Quick Facts
- NPI
- 1780610535
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile